Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Taro Pharmaceutical Industries - 31 Year Stock Price History | TARO

Historical daily share price chart and data for Taro Pharmaceutical Industries since 1993 adjusted for splits and dividends. The latest closing stock price for Taro Pharmaceutical Industries as of April 24, 2024 is 42.20.
  • The all-time high Taro Pharmaceutical Industries stock closing price was 150.25 on February 05, 2015.
  • The Taro Pharmaceutical Industries 52-week high stock price is 45.76, which is 8.4% above the current share price.
  • The Taro Pharmaceutical Industries 52-week low stock price is 24.69, which is 41.5% below the current share price.
  • The average Taro Pharmaceutical Industries stock price for the last 52 weeks is 38.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Taro Pharmaceutical Industries Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 42.1282 41.7600 43.3300 40.9700 42.2000 1.01%
2023 33.7675 29.2700 42.3100 23.0000 41.7800 43.87%
2022 37.1970 45.6100 50.3000 27.6700 29.0400 -42.05%
2021 68.5467 73.9800 79.9500 47.6000 50.1100 -31.75%
2020 66.8601 88.5100 88.7300 54.4000 73.4200 -16.50%
2019 90.8627 85.9700 108.8800 74.1800 87.9300 3.89%
2018 91.6044 90.7021 105.4853 78.2500 84.6400 -7.59%
2017 96.7330 94.1749 110.5501 85.0775 91.5944 -0.53%
2016 113.9046 132.1475 135.3578 81.9460 92.0842 -31.89%
2015 127.2747 128.9547 150.2547 112.9206 135.1916 4.29%
2014 113.4169 86.1797 143.6678 86.1797 129.6282 49.84%
2013 57.8521 42.6787 86.6433 40.2819 86.5121 104.00%
2012 35.6651 25.7349 42.7837 25.4550 42.4076 64.34%
2011 17.0126 12.5526 25.8049 12.3339 25.8049 103.59%
2010 10.7972 8.3101 12.6838 8.1351 12.6750 63.18%
2009 7.9261 7.0854 8.6949 7.0854 7.7677 15.32%
2008 7.5891 6.6918 9.4472 6.3419 6.7355 0.00%
2007 6.7259 8.6250 9.0099 5.0298 6.7355 -23.00%
2006 11.0554 12.2814 14.8444 8.4325 8.7474 -28.42%
2005 23.1485 29.8375 30.2574 11.4241 12.2202 -58.95%
2004 36.2447 54.7677 58.1967 16.6114 29.7675 -47.24%
2003 44.4515 33.4152 63.0777 26.3648 56.4209 71.54%
2002 27.2617 33.5377 34.3424 18.8945 32.8903 -5.88%
2001 27.8797 13.5323 42.4251 11.7566 34.9460 157.24%
2000 6.8710 6.3419 15.0631 3.8008 13.5848 114.21%
1999 4.4215 2.1606 8.2576 2.1606 6.3419 186.56%
1998 2.2759 2.4055 3.0616 1.6970 2.2131 -6.99%
1997 3.1157 3.0091 5.1391 1.9419 2.3793 -14.73%
1996 3.0423 3.0616 3.6083 2.2962 2.7904 -5.48%
1995 3.1781 3.2278 3.7177 2.7336 2.9523 -8.54%
1994 2.7325 3.3328 3.7701 1.9944 3.2278 -4.77%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.587B $0.573B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.403B 28.11
Chugai Pharmaceutical (CHGCY) Japan $55.239B 23.99
Takeda Pharmaceutical (TAK) Japan $42.345B 6.86
Merck (MKGAF) Germany $20.744B 19.57
Astellas Pharma (ALPMY) Japan $17.174B 24.33
Shionogi (SGIOY) Japan $14.546B 12.59
Sandoz Group AG (SDZNY) Switzerland $14.473B 0.00
Neurocrine Biosciences (NBIX) United States $13.940B 57.89
United Therapeutics (UTHR) United States $11.034B 11.82
Catalent (CTLT) United States $10.140B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.624B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.909B 7.01
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.972B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.345B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.078B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.946B 0.00
Evotec AG (EVO) Germany $2.711B 0.00
Summit Therapeutics (SMMT) United States $2.617B 0.00
Indivior (INDV) United States $2.569B 11.94
Corcept Therapeutics (CORT) United States $2.394B 24.21
Dyne Therapeutics (DYN) United States $2.192B 0.00
PTC Therapeutics (PTCT) United States $1.947B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.915B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.738B 17.96
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.658B 9.82
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Ardelyx (ARDX) United States $1.487B 0.00
Soleno Therapeutics (SLNO) United States $1.341B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.301B 12.22
4D Molecular Therapeutics (FDMT) United States $1.269B 0.00
Pacira BioSciences (PCRX) United States $1.247B 12.41
Collegium Pharmaceutical (COLL) United States $1.175B 7.23
Xencor (XNCR) United States $1.123B 0.00
Cronos Group (CRON) Canada $0.944B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.943B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.903B 0.00
Cassava Sciences (SAVA) United States $0.889B 0.00
USANA Health Sciences (USNA) United States $0.861B 13.56
ARS Pharmaceuticals (SPRY) United States $0.820B 0.00
Enliven Therapeutics (ELVN) United States $0.813B 0.00
Sage Therapeutics (SAGE) United States $0.778B 0.00
Relay Therapeutics (RLAY) United States $0.774B 0.00
Ocular Therapeutix (OCUL) United States $0.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Silence Therapeutics (SLN) United Kingdom $0.674B 0.00
Savara (SVRA) United States $0.648B 0.00
Siga Technologies (SIGA) United States $0.623B 9.22
Lyell Immunopharma (LYEL) United States $0.622B 0.00
ProKidney (PROK) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.575B 0.00
Korro Bio (KRRO) United States $0.545B 0.00
OmniAb (OABI) United States $0.543B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.542B 0.00
Altimmune (ALT) United States $0.537B 0.00
Exscientia (EXAI) United Kingdom $0.529B 0.00
KalVista Pharmaceuticals (KALV) United States $0.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.448B 0.00
Heron Therapeutics (HRTX) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.400B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.397B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Tourmaline Bio (TRML) United States $0.387B 0.00
Nature's Sunshine Products (NATR) United States $0.372B 20.81
Harrow (HROW) United States $0.365B 0.00
Bioventus (BVS) United States $0.341B 0.00
Aquestive Therapeutics (AQST) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.278B 0.00
Nanobiotix S.A (NBTX) France $0.269B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Nektar Therapeutics (NKTR) United States $0.261B 0.00
Black Diamond Therapeutics (BDTX) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Avita Medical (RCEL) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.229B 0.00
Acrivon Therapeutics (ACRV) United States $0.222B 0.00
Foghorn Therapeutics (FHTX) United States $0.220B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Telomir Pharmaceuticals (TELO) United States $0.172B 0.00
MediWound (MDWD) Israel $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.148B 0.00
Incannex Healthcare (IXHL) Australia $0.145B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.132B 2.79
VAXART, INC (VXRT) United States $0.132B 0.00
Elite Pharmaceuticals (ELTP) United States $0.132B 12.32
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Inotiv (NOTV) United States $0.125B 0.00
Citius Pharmaceuticals (CTXR) United States $0.122B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
Relmada Therapeutics (RLMD) United States $0.118B 0.00
OptiNose (OPTN) United States $0.109B 0.00
FibroGen (FGEN) United States $0.106B 0.00
Eliem Therapeutics (ELYM) United States $0.104B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.087B 7.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
JanOne (JAN) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.93
MEI Pharma (MEIP) United States $0.022B 1.12
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.90